Kim, Victor
Jeong, Stephanie
Zhao, Huaqing
Kesimer, Mehmet
Boucher, Richard C.
Wells, J. Michael
Christenson, Stephanie A.
Han, MeiLan K.
Dransfield, Mark
Paine, Robert III
Cooper, Christopher B.
Barjaktarevic, Igor
Bowler, Russell
Curtis, Jeffrey L.
Kaner, Robert J.
O’Beirne, Sarah L.
O’Neal, Wanda K.
Rennard, Stephen I.
Martinez, Fernando J.
Woodruff, Prescott G.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (U01 HL137880, U24 HL141762)
Article History
Received: 5 August 2020
Accepted: 2 November 2020
First Online: 18 November 2020
Competing interests
: In the past three years, Victor Kim has received personal fees from Gala Therapeutics, AstraZeneca, and Boehringer Ingelheim outside of the submitted work. Jeffrey L. Curtis reports a grant from NIH/NHLBI during the conduct of this study; grants from NIH/NHBLI, NIH/NIAID, the Department of Veterans Affairs, and the Department of Defense outside the submitted work; and personal fees from AstraZeneca outside the submitted work. Stephanie Jeong, Huaqing Zhao, Mehmet Kesimer, Richard C. Boucher, Stephanie A. Christenson, Meilan K. Han, Mark Dransfield, Robert Paine III, Christopher B. Cooper, Igor Barjaktarevic, Russell Bowler, Robert J. Kaner, Sara L. O’Beirne, Wanda K. O’Neal, and Fernando J. Martinez report no conflicts of interest. J. Michael Wells reports grants from NIH/NHLBI, during the conduct of the study; grants from NIH/NCATS, grants from Bayer, grants and other from GSK, other from Boehringer Ingelheim, grants and other from Mereo BioPharma, other from ICON, other from PRA, other from Vertex Pharmaceuticals, outside the submitted work. Stephen I. Rennard was employed by AstraZeneca until November, 2019 and has consulted for GSK and BerGenBio. Prescott G Woodruff reports personal fees from Glaxosmithkline, personal fees from NGM biopharmaceuticals, personal fees from Amgen, personal fees from Glenmark Pharmaceuticals, personal fees from Theravance, personal fees from Clarus Ventures, personal fees from Astra Zeneca, personal fees from 23andMe, personal fees from Sanofi, personal fees from Regeneron, personal fees from Genentech, outside the submitted work.